About 2 results found for searched term "Abarelix" (0.416 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M13376 | Abarelix | LHRH/GnRH |
| R3827; PPI 149 | ||
| Abarelix (R3827) is the first approved antagonist for the study of GnRH in advanced prostate cancer. Sequence:Ac-{d-2-Nal}-{d-4-Cpa}-{d-3-Pal}-S-{NMyr}-{d-Asp}-L-K(ipr)-P-{d-Ala}-NH2 | ||
| M13983 | Abarelix Acetate | LHRH/GnRH |
| PPI 149 Acetate; R 3827 Acetate | ||
| Abarelix Acetate (PPI 149 Acetate; R 3827 Acetate) is a potent gonadotrophin-releasing hormone (GnRH) antagonist, used for prostate cancer research. | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.